Epidermal growth factor receptor gene is highly conserved in pancreatic cancer cells [7]

Pancreas

Volumn 31, Issue 3, 2005, Pages 299-

  Mimori, Koshi ^a   Nagahara, Hisashi ^a   Barnard, Graham F ^a   Mori, Masaki ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ASPIRATION BIOPSY; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CELL PROLIFERATION; DNA EXTRACTION; GENE MUTATION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; PANCREAS CANCER; PRIORITY JOURNAL; RECEPTOR GENE; RECEPTOR UPREGULATION;

CONSERVED SEQUENCE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PANCREATIC NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 25844443385     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000181484.04528.6d     Document Type: Letter

References (7)

1. Murphy LO, Cluck MW, Lovas S, et al. Pancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditions. Br J Cancer. 2001;84:926-935.
2. Murphy LO, Abdel-Wahab YH, Wang QJ, et al. Receptors and ligands for autocrine growth pathways are up-regulated when pancreatic cancer cells are adapted to serum-free culture. Pancreas. 2001;22:293-298.
3. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004;350:2129-2139.
4. Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. 2004;304:1497-1500.
5. Nagahara H, Mimori K, Ohta M, et al. Somatic mutations of epidermal growth factor receptor in colorectal carcinoma. Clin Cancer Res. 2005;11:1368-1371.
6. Funatomi H, Itakura J, Ishiwata T, et al. Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy. Int J Cancer. 1997;72:512-517.
7. Xiong HQ, Rosenberg A, LoBuglio A, et al. Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial. J Clin Oncol. 2004;22:2610-2616.